Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 233-240 , February 2010

Anhedonia and altered cardiac atrial natriuretic peptide following chronic stressor and endotoxin treatment in mice

Received 15 January 2009 ,Revised 24 April 2009 ,Accepted 17 June 2009.

References 

  1. Anisman H, Gibb J, Hayley S. Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology (Berl.). 2008;199:231–244
  2. Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. In:  Dantzer R,  Wollman EE,  Yirmiya R editor. Cytokines, Stress and Depression. New York: Kluwer Academic/Plenum Publishers; 1999;
  3. Anisman H, Merali Z, Hayley S. Sensitization associated with stressors and cytokine treatments. Brain Behav. Immun. 2003;17:86–93
  4. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 2008;85:1–74
  5. Anisman H, Prakash P, Merali Z, Poulter MO. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav. Brain Res. 2007;181:180–190
  6. Ayensu WK, Pucilowski O, Mason GA, Overstreet DH, Rezvani AH, Janowsky DS. Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol. Behav. 1995;57:165–169
  7. Blunck R, Scheel O, Muller M, Brandenburg K, Seitzer U, Seydel U. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J. Immunol. 2001;166:1009–1015
  8. Dalack G, Roose S. Perspectives on the relationship between cardiovascular disease and affective disorder. J. Clin. Psychiatry. 1990;51:4–11
  9. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46–56
  10. Gibb J, Hayley S, Gandhi R, Poulter MO, Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav. Immun. 2008;22:573–589
  11. Goetze JP, Videbaek R, Boesgaard S, Aldershvile J, Rehfeld JF, Carlsen J. Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J. Heart Lung Transplant. 2004;23:80–87
  12. Grabie N, Hsieh DT, Buono C, Westrich JR, Allen JA, Pang H, et al. Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am. J. Pathol. 2003;163:2413–2420
  13. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol. Behav. 2005;84:697–706
  14. Grippo AJ, Moffitt JA, Johnson AK. Cardiovascular alterations and autonomic imbalance in an experimental model of depression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002;282:R1333–R1341
  15. Gutkowska J, Paquette A, Wang D, Lavoie JM, Jankowski M. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;293:R267–R275
  16. Hofmann U, Heuer S, Meder K, Boehler J, Lange V, Quaschning T, et al. The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium. Cytokine. 2007;39:157–162
  17. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 2000;23:477–501
  18. Inagaki H, Kuwahara M, Tsubone H. Effects of psychological stress on autonomic control of heart in rats. Exp. Anim. 2004;53:373–378
  19. Iyer V, Edelman E, Lilly L. Pathophysiology of heart disease: a collaborative project of medical students and faculty. In:  Lilly L editors. Pathophysiology of Heart Disease. Lippincott Williams & Wilkins; 2006;p. 473
  20. Johnson JD, O’Connor KA, Hansen MK, Watkins LR, Maier SF. Effects of prior stress on LPS-induced cytokine and sickness responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003;284:R422–R432
  21. Kim EM, Grace MK, Welch CC, Billington CJ, Levine AS. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 1999;276:R1320–R1326
  22. Lesperance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J. Psychosom. Res. 2000;48:379–391
  23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 2001;25:402–408
  24. Lumbers ER. Angiotensin and aldosterone. Regul. Pept. 1999;80:91–100
  25. Maes M. Evidence for an immune response in major depression: areview and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1995;19:11–38
  26. Mekontso-Dessap A, Brochard L. BNP in intensive care unit: what prospect for the patient under mechanical ventilation. Réanimation. 2006;15:48–54
  27. Michener ML, Gierse JK, Seetharam R, Fok KF, Olins PO, Mai MS, et al. Proteolytic processing of atriopeptin prohormone. Mol. Pharmacol. 1986;30:552–557
  28. Miller GE, Chen E, Sze J, Marin T, Arevalo J, Doll M, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol. Psychiatry. 2008;64:266–272
  29. Mockel M, Muller R, Vollert JO, Muller C, Carl A, Peetz D, et al. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin. Chem. 2005;51:1624–1631
  30. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry. 1998;55:580–592
  31. O’Donoghue M, Januzzi JL. N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure. Expert Rev. Cardiovasc. Ther. 2005;3:487–496
  32. Packer M. Current role of beta-adrenergic blockers in the management of chronic heart failure. Am. J. Med. 2001;110:81–94
  33. Politi P, Minoretti P, Piaggi N, Brondino N, Emanuele E. Elevated plasma N-terminal ProBNP levels in unmedicated patients with major depressive disorder. Neurosci. Lett. 2007;417:322–325
  34. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31
  35. Redei E, Ahmadiyeh N, Baum A, Sasso D, Slone J, Solberg L, et al. Novel animal models of affective disorders. Semin. Clin. Neuropsychiatry. 2001;6:43–67
  36. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry. 2001;58:445–452
  37. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol. Rev. 1992;44:479–602
  38. Shanshan P, Yan Z, Aiyun L, Chen P. Effect of exercise on gene expression of atrial natriuretic peptide receptor of kidney. Life Sci. 2005;76:1921–1928
  39. Shigemi K, Morimoto T, Itoh T, Natsuyama T, Hashimoto S, Tanaka Y. Regulation of vascular compliance and stress relaxation by the sympathetic nervous system. Jpn. J. Physiol. 1991;41:577–588
  40. Silberman DM, Wald M, Genaro AM. Effects of chronic mild stress on lymphocyte proliferative response. Participation of serum thyroid hormones and corticosterone. Int. Immunopharmacol. 2002;2:487–497
  41. Sullivan DR, West M, Jeremy R. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease. Heart Lung Circ. 2005;14:78–84
  42. Takemura G, Takatsu Y, Doyama K, Itoh H, Saito Y, Koshiji M, et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J. Am. Coll. Cardiol. 1998;31:754–765
  43. Tannenbaum B, Tannenbaum GS, Sudom K, Anisman H. Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Res. 2002;953:82–92
  44. Tavener SA, Kubes P. Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am. J. Physiol. Heart Circ. Physiol. 2006;290:H800–H806
  45. Tavener SA, Long EM, Robbins SM, McRae KM, Van Remmen H, Kubes P. Immune cell Toll-like receptor 4 is required for cardiac myocyte impairment during endotoxemia. Circ. Res. 2004;95:700–707
  46. Tse MY, Watson JD, Sarda IR, Flynn TG, Pang SC. Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol. Cell. Biochem. 2001;219:99–105
  47. Weber M, Mitrovic V, Hamm C. B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide—diagnostic role in stable coronary artery disease. Exp. Clin. Cardol. 2006;11:99–101
  48. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology. 1987;93:358–364
  49. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003;29:1696–1702
  50. Worthman CM, Stallings JF. Hormone measures in finger-prick blood spot samples: new field methods for reproductive endocrinology. Am. J. Phys. Anthropol. 1997;104:1–21
  51. Wright CE, Ebrecht M, Mitchell R, Anggiansah A, Weinman J. The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J. Psychosom. Res. 2005;59:415–424
  52. Zorn-Pauly K, Pelzmann B, Lang P, Machler H, Schmidt H, Ebelt H, et al. Endotoxin impairs the human pacemaker current If. Shock. 2007;28:655–661

PII: S0306-4530(09)00202-9

doi: 10.1016/j.psyneuen.2009.06.010

Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 233-240 , February 2010

Article Tools

* Image Usage & Resolution